Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.69 |
| ▸ | XDH | P47989 | 3/20 | 0.61 |
| ▸ | POLA1 | P09884 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5352883 | 0.90 | XDH (0.67) | GDAXDHPOLA1 | |
| SCHEMBL1965519 | 0.88 | GDA (0.71) | GDAXDHPOLA1 | |
| SCHEMBL3072990 | 0.83 | GDA (0.67) | GDAXDH | |
| SCHEMBL27569987 | 0.82 | GDA (0.59) | GDAXDHPOLA1 | |
| SCHEMBL27550540 | 0.82 | GDA (0.59) | GDAXDHPOLA1 | |
| SCHEMBL219478 | 0.82 | GDA (1.00) | GDAXDHPOLA1 | |
| SCHEMBL25398222 | 0.82 | GDA (0.58) | GDAPOLA1 | |
| SCHEMBL19466100 | 0.81 | GDA (0.76) | GDAXDHPOLA1 | |
| SCHEMBL29411658 | 0.80 | GDA (0.76) | GDAXDHPOLA1 | |
| SCHEMBL31093422 | 0.80 | GDA (0.74) | GDAXDHPOLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023054391-A1 | NUCLEIC ACID STRAND CLEAVING METHOD, NUCLEIC ACID STRAND CLEAVING DEVICE, DOUBLE-STRANDED DNA PRODUCTION METHOD, AND DOUBLE-STRANDED DNA PRODUCTION DEVICE | 国立研究開発法人科学技術振興機構 | 2023-04-06 | — | — | WO | disclosed |
| WO-1997032589-A1 | COMBINATIONS FOR TREATMENT OF PROLIFERATIVE DISEASES | NOVARTIS AG (CH) | 1997-09-12 | — | — | WO | disclosed |
| WO-1997032604-A1 | ANTIPROLIFERATIVE COMBINATIONS, CONTAINING RAF-TARGETED OLIGONUCLEOTIDES AND CHEMOTHERAPEUTIC COMPOUNDS | NOVARTIS AG (CH) | 1997-09-12 | — | — | WO | disclosed |